NovaBridge Biosciences (NBP) Accumulated Depreciation & Amortization (2021 - 2023)

NovaBridge Biosciences (NBP) reported Accumulated Depreciation & Amortization of $5.1 billion for Q4 2023, down 40.72% year-over-year from $8.5 billion in Q4 2022, and down 40.72% quarter-over-quarter from $8.5 billion in Q4 2022.

NovaBridge Biosciences (NBP) Accumulated Depreciation & Amortization (2021 - 2023) Analysis & Trends

NovaBridge Biosciences (NBP) has 3 years of Accumulated Depreciation & Amortization data on file, last reported at $5.1 billion in Q4 2023.

  • Accumulated Depreciation & Amortization for Q4 2023 came in at $5.1 billion, down 40.72% year-over-year; the trailing twelve-month figure through Dec 2023 was $5.1 billion (down 40.72% YoY), and the FY2023 annual result was $5.1 billion, down 42.52% from the prior year.
  • Accumulated Depreciation & Amortization slipped to $5.1 billion in Q4 2023 per NBP's latest filing, from $8.5 billion in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $8.5 billion in Q4 2022 and troughed at $5.1 billion in Q4 2023.
  • A 3-year average of $6.9 billion and a median of $7.1 billion in 2021 frame the typical range for Accumulated Depreciation & Amortization.
  • The sharpest annual moves came in 2022 and 2023: Accumulated Depreciation & Amortization gained 19.58% in 2022, then sank 40.72% in 2023.
  • A 3-year view of Accumulated Depreciation & Amortization shows it stood at $7.1 billion in 2021, then grew by 19.58% to $8.5 billion in 2022, then sank by 40.72% to $5.1 billion in 2023.
  • Business Quant data shows NBP's Accumulated Depreciation & Amortization at $5.1 billion in Q4 2023, $8.5 billion in Q4 2022, and $7.1 billion in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn -
2 Belite Bio 55,234.00 Bn 55,234.00 Bn -
3 Quantum Biopharma 17,823.14 Bn 17,823.14 Bn -
4 Legend Biotech 3,624.50 Bn 3,624.21 Bn 242.10 Mn
5 Akari Therapeutics 1,745.73 Bn 1,745.73 Bn -
6 Evaxion A 1,540.85 Bn 1,540.84 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 112.57 Bn 105.33 Bn 2.59 Bn
9 Abivax 93.46 Bn 93.46 Bn -
10 NovaBridge Biosciences 331.49 Mn 120.65 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 5.07 Bn
Dec 31, 2023 5.07 Bn
Dec 31, 2022 8.55 Bn
Dec 31, 2022 8.55 Bn
Dec 31, 2021 7.15 Bn
Dec 31, 2021 7.15 Bn